- Home
- ABP vs TPST Comparison
ABP vs TPST Comparison
Compare ABP & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABP
- TPST
- Stock Information
- Founded
- ABP N/A
- TPST 2011
- Country
- ABP United States
- TPST United States
- Employees
- ABP N/A
- TPST N/A
- Industry
- ABP Biotechnology: Pharmaceutical Preparations
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- ABP Health Care
- TPST Health Care
- Exchange
- ABP Nasdaq
- TPST Nasdaq
- Market Cap
- ABP 29.8M
- TPST 27.2M
- IPO Year
- ABP 2022
- TPST N/A
- Fundamental
- Price
- ABP N/A
- TPST $0.89
- Analyst Decision
- ABP
- TPST Strong Buy
- Analyst Count
- ABP 0
- TPST 4
- Target Price
- ABP N/A
- TPST $20.00
- AVG Volume (30 Days)
- ABP N/A
- TPST 3.3M
- Earning Date
- ABP N/A
- TPST 11-12-2024
- Dividend Yield
- ABP N/A
- TPST N/A
- EPS Growth
- ABP N/A
- TPST N/A
- EPS
- ABP N/A
- TPST N/A
- Revenue
- ABP N/A
- TPST N/A
- Revenue This Year
- ABP N/A
- TPST N/A
- Revenue Next Year
- ABP N/A
- TPST N/A
- P/E Ratio
- ABP N/A
- TPST N/A
- Revenue Growth
- ABP N/A
- TPST N/A
- 52 Week Low
- ABP N/A
- TPST $0.83
- 52 Week High
- ABP N/A
- TPST $6.00
- Technical
- Relative Strength Index (RSI)
- ABP N/A
- TPST 34.45
- Support Level
- ABP N/A
- TPST $0.94
- Resistance Level
- ABP N/A
- TPST $1.16
- Average True Range (ATR)
- ABP 0.00
- TPST 0.10
- MACD
- ABP 0.00
- TPST 0.00
- Stochastic Oscillator
- ABP 0.00
- TPST 15.50
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.